乌干达卡塞塞地区选定卫生机构开展社区主导的抗逆转录病毒治疗(CCLAD)中患者入组的障碍。
Barriers to enrolment of clients into community client led anti-retroviral therapy delivery (CCLAD) in selected health facilities in Kasese district, Uganda.
机构信息
Faculty of Health Sciences, Uganda Martyrs University, Kampala.
Department of Health and community Systems strengthening, Baylor-Uganda, Kampala.
出版信息
Afr Health Sci. 2024 Mar;24(1):42-58. doi: 10.4314/ahs.v24i1.7.
BACKGROUND
Community Client Led Anti-retroviral therapy Delivery (CCLAD) Model has been associated with increased community participation and ownership, which leads to better treatment outcomes with reduced workload and increased client satisfaction of health services.
AIM
To explore the barriers to enrolment of eligible clients into CCLAD in selected health facilities in Kasese District, Uganda.
MATERIALS & METHODS: Analytical cross-sectional study utilizing mixed method approach was conducted among 384 PLWHIV attending public health facilities of Kasese District. Sampling was done by simple random sampling method. Data was collected using researcher-administered questionnaire method and interview guide.
RESULTS
Most of the respondents 253(65.9%) had not yet enrolled into CCLAD. This was due to some client-related factors such as non-disclosure of HIV sero-status (p=0.040), person to whom HIV sero-status was disclosed to (=0.009), not having ever heard about CCLAD (=0.000), incorrect description of CCLAD (=0.000), limited knowledge of advantages of CCLAD (=0.000) or disadvantages of CCLAD (=0.003). Other barriers were; failure to have access to organizations or groups that support PLWHIV to get treatment (=0.025) and duration of ART refills [AOR=1.637, 95% CI (0.820 - 3.270)].
CONCLUSION
Adoption of CCLAD model among PLWHIV in Kasese District is still low.
背景
社区客户主导的抗逆转录病毒治疗模式(CCLAD)与增加社区参与度和所有权有关,从而通过减少工作量和提高客户对卫生服务的满意度,带来更好的治疗效果。
目的
探讨在乌干达卡塞塞地区选定的卫生机构中,将符合条件的患者纳入 CCLAD 模式所面临的障碍。
材料与方法
采用混合方法的分析性横断面研究,在卡塞塞区的 384 名艾滋病毒感染者中进行。采用简单随机抽样法进行抽样。使用研究者管理的问卷方法和访谈指南收集数据。
结果
大多数受访者 253 人(65.9%)尚未参与 CCLAD。这是由于一些与患者相关的因素,如未披露 HIV 血清状况(p=0.040)、向谁披露 HIV 血清状况(=0.009)、从未听说过 CCLAD(=0.000)、对 CCLAD 的描述不正确(=0.000)、对 CCLAD 的优势的了解有限(=0.000)或劣势(=0.003)。其他障碍包括:无法获得支持 HIV 感染者接受治疗的组织或团体(=0.025)以及接受 ART 药物补充的时间[比值比(AOR)=1.637,95%置信区间(0.820-3.270)]。
结论
卡塞塞地区的 HIV 感染者采用 CCLAD 模式的比例仍然较低。